Growth Metrics

Neuronetics (STIM) Liabilities and Shareholders Equity (2017 - 2025)

Neuronetics (STIM) has disclosed Liabilities and Shareholders Equity for 9 consecutive years, with $145.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 96.26% to $145.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $563.0 million, a 44.15% increase, with the full-year FY2024 number at $140.9 million, up 21.65% from a year prior.
  • Liabilities and Shareholders Equity was $145.5 million for Q3 2025 at Neuronetics, up from $134.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $152.3 million in Q1 2021 to a low of $74.1 million in Q3 2024.
  • A 5-year average of $122.3 million and a median of $123.0 million in 2022 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 22.01% in 2023, then skyrocketed 96.26% in 2025.
  • Neuronetics' Liabilities and Shareholders Equity stood at $141.2 million in 2021, then dropped by 17.23% to $116.9 million in 2022, then fell by 0.9% to $115.8 million in 2023, then rose by 21.65% to $140.9 million in 2024, then grew by 3.24% to $145.5 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Liabilities and Shareholders Equity are $145.5 million (Q3 2025), $134.6 million (Q2 2025), and $142.0 million (Q1 2025).